Trinseo (NYSE: TSE), the global materials company and manufacturer of plastics, latex binders and synthetic rubber, is offering medical equipment manufacturers and molders medical-grade MAGNUM™ ABS Resins. The material features the advantages of Trinseo’s mass polymerization technology combined with the properties needed most for medical applications to assure the integrity of end-use applications.
Trinseo’s MAGNUM™ 8391 MED ABS Resins, are part of the company’s line of performance plastics tailored for medical device applications. Trinseo’s proprietary polymerization process results in a material that is highly consistent from lot-to-lot in terms of color, rheology and physical properties. The process results in brilliant whiteness of the material for ease of coloring and less pigment use, and results in lower residual monomers and oligomers.
Medical-industry requirements found in MAGNUM™ 8391 MED include biocompatibility, chemical resistance, sterilization options, and comprehensive regulatory support. The material also offers an extended notification of change as well as the versatility of secondary operations common in medical equipment, such as spraying, plating, solvent bonding and ultrasonic welding.
To ensure the quality required for medical applications, Trinseo adheres to strict production guidelines. Our medical manufacturing facilities and related global departments are ISO 13485:2016 certified, which places a special emphasis on risk management and process validation.
Trinseo has a history of providing the medical device industry with materials for single- and multiple-use devices and equipment housings. As a manufacturer focused on resin quality and product stewardship, Trinseo is committed to supporting the medical equipment industry with superior product quality, outstanding consistency, and the assurance of global supply.
Trinseo (NYSE: TSE), a specialty material solutions provider, partners with companies to bring ideas to life in an imaginative, smart, and sustainability-focused manner by combining its premier expertise, forward-looking innovations and best-in-class materials to unlock value for companies and consumers.
From design to manufacturing, Trinseo taps into decades of experience in diverse material solutions to address customers’ unique challenges in a wide range of industries, including consumer goods, mobility, building and construction, and medical.
Trinseo’s approximately 3,400 employees bring endless creativity to reimagining the possibilities with clients all over the world from the company’s locations in North America, Europe, and Asia Pacific. Trinseo reported net sales of approximately $4.8 billion in 2021. Discover more by visiting www.trinseo.com and connecting with Trinseo on LinkedIn, Twitter, Facebook and WeChat.
Cautionary Note on Forward-Looking Statements
This press release may contain forward-looking statements including, without limitation, statements concerning plans, objectives, goals, projections, strategies, future events or performance, and underlying assumptions and other statements, which are not statements of historical facts or guarantees or assurances of future performance. Forward-looking statements may be identified by the use of words like "expect," "anticipate," "intend," "forecast," "outlook," "will," "may," "might," "see," "tend," "assume," "potential," "likely," "target," "plan," "contemplate," "seek," "attempt," "should," "could," "would" or expressions of similar meaning. Forward-looking statements reflect management’s evaluation of information currently available and are based on our current expectations and assumptions regarding our business, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. Factors that might cause future results to differ from those expressed by the forward-looking statements include, but are not limited to, our ability to successfully execute our transformation strategy and business strategy; our ability to integrate acquired businesses; global supply chain volatility, increased costs or disruption in the supply of raw materials or increased costs for transportation of our products; the nature of investment opportunities presented to the Company from time to time; and those factors discussed in our Annual Report on Form 10-K, under Part I, Item 1A —"Risk Factors" and elsewhere in our other reports, filings and furnishings made with the U.S. Securities and Exchange Commission from time to time. As a result of these or other factors, our actual results may differ materially from those contemplated by the forward-looking statements. Therefore, we caution you against relying on any of these forward-looking statements. The forward-looking statements included in this press release are made only as of the date hereof. We undertake no obligation to publicly update or revise any forward-looking statement as a result of new information, future events or otherwise, except as otherwise required by law.